NO131836B - - Google Patents
Download PDFInfo
- Publication number
- NO131836B NO131836B NO1543/71A NO154371A NO131836B NO 131836 B NO131836 B NO 131836B NO 1543/71 A NO1543/71 A NO 1543/71A NO 154371 A NO154371 A NO 154371A NO 131836 B NO131836 B NO 131836B
- Authority
- NO
- Norway
- Prior art keywords
- dibenzothiophene
- formula
- compound
- bis
- reaction
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 43
- IYYZUPMFVPLQIF-UHFFFAOYSA-N dibenzothiophene Chemical compound C1=CC=C2C3=CC=CC=C3SC2=C1 IYYZUPMFVPLQIF-UHFFFAOYSA-N 0.000 claims description 25
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 12
- 150000001412 amines Chemical class 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052794 bromium Inorganic materials 0.000 claims description 7
- 239000000460 chlorine Substances 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 150000003335 secondary amines Chemical class 0.000 claims description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- 125000002947 alkylene group Chemical group 0.000 claims description 5
- 150000002431 hydrogen Chemical class 0.000 claims description 5
- RZNTXTAMLMPPJL-UHFFFAOYSA-N 2-bromo-1-[8-(2-bromoacetyl)dibenzothiophen-2-yl]ethanone Chemical compound C1=C(C(=O)CBr)C=C2C3=CC(C(=O)CBr)=CC=C3SC2=C1 RZNTXTAMLMPPJL-UHFFFAOYSA-N 0.000 claims description 4
- 239000007818 Grignard reagent Substances 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 230000000840 anti-viral effect Effects 0.000 claims description 4
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 4
- 150000004795 grignard reagents Chemical class 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- BVXCVCPNBFGSMH-UHFFFAOYSA-N 2-(diethylamino)-1-[8-[2-(diethylamino)acetyl]dibenzothiophen-2-yl]ethanone Chemical compound C(C)N(CC)CC(=O)C1=CC2=C(SC3=C2C=C(C=C3)C(CN(CC)CC)=O)C=C1 BVXCVCPNBFGSMH-UHFFFAOYSA-N 0.000 claims description 2
- LHEGATUXJNBGRM-UHFFFAOYSA-N 2-(dimethylamino)-1-[8-[2-(dimethylamino)acetyl]dibenzothiophen-2-yl]ethanone Chemical compound C1=C(C(=O)CN(C)C)C=C2C3=CC(C(=O)CN(C)C)=CC=C3SC2=C1 LHEGATUXJNBGRM-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 239000000203 mixture Substances 0.000 description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 12
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- -1 methylene, 1,2-ethylene, 1,3-propylene, 1,4-butylene, 1,5-pentylene, 1,6-hexylene Chemical group 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 9
- 241000700605 Viruses Species 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 4
- IFGFNNSJQLFDTL-UHFFFAOYSA-N 2-chloro-1-[8-(2-chloroacetyl)dibenzothiophen-2-yl]ethanone Chemical compound ClCC(=O)C1=CC2=C(SC3=C2C=C(C=C3)C(CCl)=O)C=C1 IFGFNNSJQLFDTL-UHFFFAOYSA-N 0.000 description 4
- 238000005917 acylation reaction Methods 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940125904 compound 1 Drugs 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 150000007514 bases Chemical class 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 2
- 239000012433 hydrogen halide Substances 0.000 description 2
- 229910000039 hydrogen halide Inorganic materials 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 239000012429 reaction media Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Inorganic materials [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000001302 tertiary amino group Chemical group 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UWYVPFMHMJIBHE-OWOJBTEDSA-N (e)-2-hydroxybut-2-enedioic acid Chemical compound OC(=O)\C=C(\O)C(O)=O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- VBPBWRXUZDIQHT-UHFFFAOYSA-N 1-(8-acetyldibenzothiophen-2-yl)ethanone Chemical compound C1=C(C(C)=O)C=C2C3=CC(C(=O)C)=CC=C3SC2=C1 VBPBWRXUZDIQHT-UHFFFAOYSA-N 0.000 description 1
- LSTRKXWIZZZYAS-UHFFFAOYSA-N 2-bromoacetyl bromide Chemical compound BrCC(Br)=O LSTRKXWIZZZYAS-UHFFFAOYSA-N 0.000 description 1
- PKRSYEPBQPFNRB-UHFFFAOYSA-N 2-phenoxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1OC1=CC=CC=C1 PKRSYEPBQPFNRB-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ATANUYPSKXKEDC-UHFFFAOYSA-N 3-chlorobutanoyl chloride Chemical compound CC(Cl)CC(Cl)=O ATANUYPSKXKEDC-UHFFFAOYSA-N 0.000 description 1
- INUNLMUAPJVRME-UHFFFAOYSA-N 3-chloropropanoyl chloride Chemical compound ClCCC(Cl)=O INUNLMUAPJVRME-UHFFFAOYSA-N 0.000 description 1
- JEGMWWXJUXDNJN-UHFFFAOYSA-N 3-methylpiperidine Chemical compound CC1CCCNC1 JEGMWWXJUXDNJN-UHFFFAOYSA-N 0.000 description 1
- CDIIZULDSLKBKV-UHFFFAOYSA-N 4-chlorobutanoyl chloride Chemical compound ClCCCC(Cl)=O CDIIZULDSLKBKV-UHFFFAOYSA-N 0.000 description 1
- KBOGMBQWZCIHNQ-UHFFFAOYSA-N 5-chloro-3-methylpentanoyl chloride Chemical compound ClCCC(C)CC(Cl)=O KBOGMBQWZCIHNQ-UHFFFAOYSA-N 0.000 description 1
- SVNNWKWHLOJLOK-UHFFFAOYSA-N 5-chloropentanoyl chloride Chemical compound ClCCCCC(Cl)=O SVNNWKWHLOJLOK-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- TXCDCPKCNAJMEE-UHFFFAOYSA-N Dibenzofuran Natural products C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 1
- 238000005967 Finkelstein reaction Methods 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 238000006683 Mannich reaction Methods 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241000709664 Picornaviridae Species 0.000 description 1
- 238000000297 Sandmeyer reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- AHJVGWQHSLZPDW-UHFFFAOYSA-N [2-[8-[2-(dimethylazaniumyl)acetyl]dibenzothiophen-2-yl]-2-oxoethyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].C1=C(C(=O)C[NH+](C)C)C=C2C3=CC(C(=O)C[NH+](C)C)=CC=C3SC2=C1 AHJVGWQHSLZPDW-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- VYVZQLUQIJAVLK-UHFFFAOYSA-N dibenzothiophene-1,2-dicarboxylic acid Chemical class C1=CC=C2C3=C(C(O)=O)C(C(=O)O)=CC=C3SC2=C1 VYVZQLUQIJAVLK-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical class O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000010952 in-situ formation Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/76—Dibenzothiophenes
Description
Foreliggende oppfinnelse angår en analogifremgangsmåte ved fremstilling av nye bis-basiske ketoner av dibenzothiofen. Forbindelsene fremstilt i henhold til denne oppfinnelse omfatter både den basiske form og farmasoytisk akseptable syreaddisjonssalter av basen, som er representert av den folgende generelle formel The present invention relates to an analogous process for the production of new bis-basic ketones from dibenzothiophene. The compounds prepared according to this invention include both the basic form and pharmaceutically acceptable acid addition salts of the base, which are represented by the following general formula
hvor hver A er forgrenet eller uforgrenet alkylen med 1-6 carbonatomer, og hver Y er (A) gruppen 1 2 hvor R og R hver er hydrogen, eller forgrenet eller uforgrenet alkyl med 1 - h carbonatomer^ eller (B) gruppen hvor n er et helt tall fra k- til 6 og R-^ er hydrogen, forgrenet eller uforgrenet alkyl med 1 - h carbonatomer, eller (C) gruppen where each A is branched or unbranched alkylene of 1-6 carbon atoms, and each Y is (A) the group 1 2 where R and R are each hydrogen, or branched or unbranched alkyl of 1-h carbon atoms^ or (B) the group where n is an integer from k- to 6 and R-^ is hydrogen, branched or unbranched alkyl of 1 - h carbon atoms, or (C) the group
De basiske ketongrupper, dvs. The basic ketone groups, i.e.
i formel I kan bindes til det tricyckliske ringsystem av dibenzothiofen ved utbytning av hvilket som helst av de fire hydrogenatomer i benzenringen, til hvilke en slik gruppe er knyttet. Således kan én av gruppene være i hvilken som helst av stillingene 1 - h i det tricykliske system, og den andre kan være i hvilke som helst av stillingene 6-9. Fortrinnsvis er én av de basiske ketongrupper bundet til 2-posisjonen og den andre er bundet til 6- eller 8-posisjonen av den tricykliske ringsystem. Det er åpenbart fra den ovenfor viste formel I, og dens beskrivelse, at forbindelsene kan ha strukturer i hvilke Y er gruppen som vist i den generelle formel II, eller hvorY er gruppen in formula I can be attached to the tricyclic ring system of dibenzothiophene by replacement of any of the four hydrogen atoms in the benzene ring to which such a group is attached. Thus, one of the groups can be in any of the positions 1-h in the tricyclic system, and the other can be in any of the positions 6-9. Preferably, one of the basic ketone groups is attached to the 2-position and the other is attached to the 6- or 8-position of the tricyclic ring system. It is apparent from the formula I shown above, and its description, that the compounds may have structures in which Y is the group as shown in the general formula II, or where Y is the group
som vist i den generelle formel III, as shown in the general formula III,
eller hvor Y er gruppen or where Y is the group
formel IV. formula IV.
, som vist i den folgende generelle , as shown in the following general
I de generelle formlene II, III og IV, har de for-12 ^ In the general formulas II, III and IV, they have for-12 ^
skjellige symboler, dvs. A, R , R og RJ de tidligere angitte betydninger. different symbols, i.e. A, R , R and RJ the previously stated meanings.
De to alkylengruppene som A representerer, kan være like eller forskjellige. Fortrinnsvis er disse grupper like. Eksempelvis kan alkylengruppene, som representeres av A, være: methylen, 1,2-ethylen, 1,3-propylen, 1,4—butylen, 1,5-pentylen, 1,6-hexylen, 2-methyl-l,<1>+-butylen, 2-ethyl-l,^-butylen, 3-methyl-l,5-pentylen. The two alkylene groups represented by A may be the same or different. Preferably, these groups are similar. For example, the alkylene groups, which are represented by A, can be: methylene, 1,2-ethylene, 1,3-propylene, 1,4-butylene, 1,5-pentylene, 1,6-hexylene, 2-methyl-1,< 1>+-butylene, 2-ethyl-1,^-butylene, 3-methyl-1,5-pentylene.
Hver aminogruppe i forbindelsene av formel II, dvs. Each amino group in the compounds of formula II, i.e.
kan være en primær, sekundær eller en tertiær aminogruppe, hvor R 1 og R 2 har de tidligere angitte betydninger. Fortrinnsvis er hver av aminogruppene, som representeres av , en tertiær aminogruppe. Heterocykliske grupper, som representeres av hver can be a primary, secondary or a tertiary amino group, where R 1 and R 2 have the previously stated meanings. Preferably, each of the amino groups, represented by , is a tertiary amino group. Heterocyclic groups, which are represented by each
, kan eksempelvis nevnes piperidino, pyrrolidino, , for example piperidino, pyrrolidino,
^-methylpiperidino, 3-methylpiperidino, ^-tert.-butylpiperidino. ^-methylpiperidino, 3-methylpiperidino, ^-tert-butylpiperidino.
Som basiske forbindelser, som representeres av formel I, kan eksempelvis nevnes: Z^-bisC^-diethylaminobutyryl)-dibenzothiofen, 2,8-bis-(diethylaminoacetyl) -dibenzo-thiof en, 2,6-bis-(>+-piperi-dinobutyryl)-dibenzothiofen, 2,8-bis-(^-morfolinobutyryl)-dibenzo-thiof en, 2,8-bis(li—C+-methylpiperidino)^utyryl}dibenzothiof en. As basic compounds, which are represented by formula I, can be mentioned, for example: piperi-dinobutyryl)-dibenzothiophene, 2,8-bis-(^-morpholinobutyryl)-dibenzothiophene, 2,8-bis(1—C+-methylpiperidino)^utyryl}dibenzothiophene.
Fra U.S. patentskrift 3.083.201 er det kjent glyoxal-derivater av dibenzofuran og dibenzothiofen. Forbindelsene ifolge denne publikasjon angis å utvise antiviral aktivitet. From the U.S. patent 3,083,201, glyoxal derivatives of dibenzofuran and dibenzothiophene are known. The compounds according to this publication are stated to exhibit antiviral activity.
Det er imidlertid funnet at en representativ forbindelse ifblge dette patentskrift ikke utviser noen aktivitet overfor encefalomyocarditis (EMC) virus. However, it has been found that a representative compound according to this patent does not exhibit any activity against encephalomyocarditis (EMC) virus.
Representative forbindelser fremstilt ifolge fore-er Representative compounds prepared according to fore-er
liggende fremgangsmåte/undersokt med hensyn på den antivirale aktivitet overfor encefalomyocarditis (EMC) virus sammenlignet med en representativ forbindelse ifolge U.S. 3.083.201, nemlig l,l'-2,8-dibenzothiof endi-yl —bis-(2,2-dihydroxyethanon) lying method/investigated with regard to the antiviral activity against encephalomyocarditis (EMC) virus compared to a representative compound according to the U.S. 3,083,201, namely 1,1'-2,8-dibenzothiophendi-yl -bis-(2,2-dihydroxyethanone)
Undersøkelsen ble utfort på folgende måte: The survey was carried out in the following way:
To grupper av mus ble innpodet med en letal dose av EMC virus. Hver mus veide ca. 20 gr og hver av de to grupper av mus besto av fra 10 til 30 dyr. Musene i en av gruppene ble behandlet både profylaktisk og terapeutisk ved subcutane injeksjoner av test-forbindelser. Injeksjonene ble gitt 28, 22 og 2 timer for innpodning med virus og 2 timer etter innpodning. Volumet av hver injeksjon av test-forbindelsene var 0.25 ml og inneholdt test-forbindelsen i et doseringsnivå på 50 mg/kg lost i sterilt vann som også inneholdt 1.05 % hydroxy-cellulose. Kontrolldyrene mottok en lik dose av det samme volum av bæreren uten test-forbindelsen. Observasjon over en 10 dagers peri-ode ga grunnlag for bestemmelse av STR, (overlevelsestidsforhold). Two groups of mice were inoculated with a lethal dose of EMC virus. Each mouse weighed approx. 20 gr and each of the two groups of mice consisted of from 10 to 30 animals. The mice in one of the groups were treated both prophylactically and therapeutically by subcutaneous injections of test compounds. The injections were given 28, 22 and 2 hours before inoculation with virus and 2 hours after inoculation. The volume of each injection of the test compounds was 0.25 ml and contained the test compound at a dosage level of 50 mg/kg dissolved in sterile water which also contained 1.05% hydroxy-cellulose. Control animals received an equal dose of the same volume of the vehicle without the test compound. Observation over a 10-day period provided the basis for determining STR, (survival time ratio).
qm-p _ midlere dodsdag for behandlede dyr qm-p _ average day of death for treated animals
blK ~ -"- -"- kontroll dyr blK ~ -"- -"- control animal
STR = 0.9-1.09 ikke aktiv STR = 0.9-1.09 not active
STR = 1.10 - 1.19 svak aktivitet STR = 1.10 - 1.19 weak activity
STR = 1.20 - 1.29 middels aktivitet STR = 1.20 - 1.29 medium activity
STR = 1.30 og storre hoy aktivitet. STR = 1.30 and greater high activity.
Resultatene av undersøkelsen var som folger The results of the survey were as follows
Som det fremgår fra tabellene utviser forbindelsene fremstilt ifolge fremgangsmåten en sterk antiviral aktivitet overfor EMC-virus. Den kjente forbindelse var inaktiv. As can be seen from the tables, the compounds produced according to the method exhibit a strong antiviral activity against EMC virus. The known connection was inactive.
Særlig foretrukne forbindelser er 2,8-bis-(dimethyl-aminoacetyl)-dibenzothiofen og 2,8-bis-(diethylaminoacetyl)-dibenzothiofen fordi disse utviser en særlig sterk aktivitet ved oral administrering. Particularly preferred compounds are 2,8-bis-(dimethylaminoacetyl)-dibenzothiophene and 2,8-bis-(diethylaminoacetyl)-dibenzothiophene because these exhibit a particularly strong activity when administered orally.
Farmasøytisk akseptable syreaddisjonssalter av de basiske forbindelser, i henhold til foreliggende oppfinnelse, er de av hvilken som helst uorganiske eller organiske syre. Egnede uorganiske syrer er eksempelvis saltsyre, hydrobromsyre, svovelsyre eller fosforsyrer og lignende. Egnede organiske syrer er eksempelvis carboxylsyrer slike som eddiksyre, propionsyre, glyeolsyre, melke-syre, pyrodruesyre, malonsyre, ravsyre, fumarsyre, maleinsyre,vinsyre, citronsyre, ascorbinsyre, eplesyre, hydroxymaleinsyre, benzoesyre, hydroxybenzoesyre, fenyleddiksyre, kanelsyre, salicylsyre, 2-fenoxy-benzoesyre og lignende, eller sulfonsyrer slike som methansulfon-syre, 2-hydroxyethansulfonsyre og lignende. Mono- eller di-syre-salter kan dannes og saltene kan være hydrerte eller i det vesent-lige vannfrie. Pharmaceutically acceptable acid addition salts of the basic compounds, according to the present invention, are those of any inorganic or organic acid. Suitable inorganic acids are, for example, hydrochloric acid, hydrobromic acid, sulfuric acid or phosphoric acids and the like. Suitable organic acids are, for example, carboxylic acids such as acetic acid, propionic acid, glyeolic acid, lactic acid, pyruvic acid, malonic acid, succinic acid, fumaric acid, maleic acid, tartaric acid, citric acid, ascorbic acid, malic acid, hydroxymaleic acid, benzoic acid, hydroxybenzoic acid, phenylacetic acid, cinnamic acid, salicylic acid, 2- phenoxybenzoic acid and the like, or sulphonic acids such as methanesulphonic acid, 2-hydroxyethanesulphonic acid and the like. Mono- or di-acid salts can be formed and the salts can be hydrated or essentially anhydrous.
Forbindelsene ifolge foreliggende oppfinnelsen kan administreres til dyr, slike som varmblodige dyr, og spesielt pattedyr, for å forhindre eller inhibitere infeksjoner av: picornavira, f.eks. encephalomyocarditis, myxo-vira, f.eks. Influenza A2 (Jap/305), arbovirus, f.eks. Semliki Forest, herpesvirus-gruppen, f.eks. herpes simplex og poxvira, f.eks. Vaccinia IHD. Når forbindelsene administreres for infeksjon, dvs. profylaktisk, er det foretrukket at administrasjonen skjer i lopet av 0 - 96 timer for dyret smittes med en patogen virus. Ved terapeutisk administrasjon for å inhibitere en infeksjon, er det foretrukket at administrasjonen skjer i lopet av 1 til 2 dager etter infeksjon av et patogent virus. The compounds according to the present invention can be administered to animals, such as warm-blooded animals, and especially mammals, to prevent or inhibit infections by: picornavirus, e.g. encephalomyocarditis, myxoviruses, e.g. Influenza A2 (Jap/305), arbovirus, e.g. Semliki Forest, herpes virus group, e.g. herpes simplex and poxviruses, e.g. Vaccinia IHD. When the compounds are administered for infection, i.e. prophylactically, it is preferred that the administration takes place within 0-96 hours before the animal is infected with a pathogenic virus. In the case of therapeutic administration to inhibit an infection, it is preferred that the administration takes place within 1 to 2 days after infection by a pathogenic virus.
Den administrerte dose vil være avhengig av den type virus for hvilket behandling gis eller profylaxis onskes, den dyreart som behandles, dets alder, helse, vekt, grad av infeksjon, arten av even-tuell annen behandling, behandlingens hyppighet og den tilsiktede effekt. Eksempelvis kan dosenivåer for de administrerte aktive bestanddeler være: intravenøst, 0,1 - 10 mg/kg, intraperitonealt, The administered dose will depend on the type of virus for which treatment is given or prophylaxis is desired, the species of animal being treated, its age, health, weight, degree of infection, the nature of any other treatment, the frequency of the treatment and the intended effect. For example, dose levels for the administered active ingredients can be: intravenously, 0.1 - 10 mg/kg, intraperitoneally,
0,1 - 50 mg/kg, subcutant, 0,1 - 2^0 mg/kg, oralt, 0,1 - 500 mg/kg 0.1 - 50 mg/kg, subcutaneous, 0.1 - 2^0 mg/kg, oral, 0.1 - 500 mg/kg
og fortrinnsvis ca. 1 - 250 mg/kg, intranasalinndrypning 0,1 - 10 and preferably approx. 1 - 250 mg/kg, intranasal drip 0.1 - 10
mg/kg, eller som aerosol 0,1 - 10 mg/kg av dyrets kroppsvekt. mg/kg, or as an aerosol 0.1 - 10 mg/kg of the animal's body weight.
Forbindelsene kan administreres opplost eller suspen-dert i hvilken som helst konvensjonell ikke-giftig, farmasøytisk bærer av en slik type som kan taes oralt, påfores topisk, i munnhulen, intranasalt eller parenteralt. The compounds may be administered dissolved or suspended in any conventional non-toxic pharmaceutical carrier of such type as may be taken orally, topically, buccally, intranasally or parenterally.
Analogifremgangsmåten for fremstilling av forbindelsene av formel I er kjennetegnet ved at The analogous method for preparing the compounds of formula I is characterized in that
(I) en forbindelse formelen (I) a compound formula
omsettes med et amin av formelen Y-H, hvor A og Y har de tidligere gitte betydninger, og Hal er klor, brom eller jod, eller (II) for fremstilling av en forbindelse av formelen: hvor z er 3 - 6 og Y kan være hvilke som helst av de tidligere angitte grupper med unntagelse av de som har hydrogen knyttet til nitrogenatomet, et dinitril av dibenzothiofen av formelen omsettes med et Grignard-reagens av formelen hvor X er brom eller klor, eller (III) for fremstilling av en forbindelse av formelen: hvor Y er et sekundært amin som tidligere angitt, en forbindelse av formelen: omsettes med formaldehyd og en forbindelse av formelen Y-H. is reacted with an amine of the formula Y-H, where A and Y have the previously given meanings, and Hal is chlorine, bromine or iodine, or (II) to produce a compound of the formula: where z is 3 - 6 and Y can be any of the previously indicated groups with the exception of those having hydrogen attached to the nitrogen atom, a dinitrile of dibenzothiophene of the formula is reacted with a Grignard reagent of the formula where X is bromine or chlorine, or (III) for the preparation of a compound of the formula: where Y is a secondary amine as previously indicated, a compound of the formula: is reacted with formaldehyde and a compound of the formula Y-H.
Ved denne reaksjon har A og Y de tidligere gitte betydninger, og hver Hal er enten klor, brom eller jod. In this reaction, A and Y have the previously given meanings, and each Hal is either chlorine, bromine or iodine.
Bis-(w-halogenalkanoyl)-dibenzothiofen-derivatet 1, i hvilket substitusjonsstillingen er 2,6- eller 2,8-, kan fremstilles ved en Friedel-Craft acylering av dibenzothiofen. Av egnede acy-leringsmidler som kan anvendes, kan de folgende eksempelvis nevnes: kloracetylklorid, bromacetylbromid, 3-klorpropionylklorid, 4--klorbutyrylklorid , 5-klorvalerylklorid , 5-klor-1!--methylvalerylklorid , 5-klor-3-methylvalerylklorid. The bis-(w-haloalkanoyl)-dibenzothiophene derivative 1, in which the substitution position is 2,6- or 2,8-, can be prepared by a Friedel-Craft acylation of dibenzothiophene. Of suitable acylating agents that can be used, the following can be mentioned, for example: chloroacetyl chloride, bromoacetyl bromide, 3-chloropropionyl chloride, 4-chlorobutyryl chloride, 5-chlorovaleryl chloride, 5-chloro-1!-methylvaleryl chloride, 5-chloro-3-methylvaleryl chloride.
Det er åpenbart for en fagmann at acyleringsreaksjonen kan utfores i et antall oppldsningsmidler katalysert av et antall It will be obvious to one skilled in the art that the acylation reaction can be carried out in a number of solvents catalyzed by a number of
Lewis-syrer. Temperaturen og reaksjonstiden kan varieres for å tillate optimale reaksjonsbetingelser. En foretrukket fremgangsmåte er å omsette en ekvivalent dibenzothiofen med 2,5 ekvivalenter av acyleringsmidlet i methylenklorid, etterfulgt ved en porsjonsvis tilsetning av aluminiumklorid. Reaksjonstemperaturen holdes under 0°C, under kontinuerlig omroring. Etter at tilsetningen er ferdig kan temperaturen heves til 25 - Lt-0°C i 12 - 36 timer. Reaksjonsblandingen opparbeides på vanlig måte ved spaltning av det dannede kompleks med isvann/HCl. Det erholdte produkt omkrystalliseres fra methylenklorid, kloroform eller lignende. Fremgangsmåten kan varieres slik at tilsetningen av acyleringsmidlet og Lewis-syren fore-går i omvendt rekkefolge, eller tilsetningen av det aromatiske hydrocarbon og Lewis-syren gjbres i omvendt rekkefolge. Det mere reaktive halogenderivat, dvs. bis-(«-jodalkanoyl)-dibenzothiofen, kan fremstilles fra det tilsvarende bis-klorderivat ved anvendelse av en halogenbyttereaksjon, under de betingelser som vanligvis anvendes i Conant-Finkelstein-reaksjonen. Lewis acids. The temperature and reaction time can be varied to allow optimal reaction conditions. A preferred method is to react one equivalent of dibenzothiophene with 2.5 equivalents of the acylating agent in methylene chloride, followed by a portionwise addition of aluminum chloride. The reaction temperature is kept below 0°C, with continuous stirring. After the addition is finished, the temperature can be raised to 25 - Lt-0°C for 12 - 36 hours. The reaction mixture is worked up in the usual way by cleavage of the formed complex with ice water/HCl. The product obtained is recrystallized from methylene chloride, chloroform or the like. The procedure can be varied so that the addition of the acylating agent and the Lewis acid takes place in reverse order, or the addition of the aromatic hydrocarbon and the Lewis acid is carried out in reverse order. The more reactive halogen derivative, i.e. bis-(«-iodoalkanoyl)-dibenzothiophene, can be prepared from the corresponding bis-chloro derivative using a halogen exchange reaction, under the conditions usually used in the Conant-Finkelstein reaction.
Hovedproduktet av Friedel-Craft-acyleringsreaksjonen er 2,8-bis-(u>-halogenalkanoyl)-dibenzothiofen. Imidlertid, er feak-sjonsforlopet slik at hovedisomeren dannes sammen med betydelige mengder av den andre isomere form av bis-(u)-halogenalkanoyl) - dibenzothiofen. Ved riktig valg av opplosningsmidler for omkrystal-lisering, kan disse isomerer adskilles. The main product of the Friedel-Craft acylation reaction is 2,8-bis-(u>-haloalkanoyl)-dibenzothiophene. However, the course of the reaction is such that the major isomer is formed along with significant amounts of the second isomeric form of bis-(u)-haloalkanoyl)-dibenzothiophene. With the correct choice of solvents for recrystallization, these isomers can be separated.
Av aminer 2, som er nyttige ved den ovenfor viste reaksjon, kan folgende eksempler nevnes: -ammoniakk eller en forbindelse som er en potensiell kilde for ammoniakk, eksempelvis hexamethy-lentetramin og lignende, primære aminer slike som ethylamin, pro-pylamin og lignende, sekundære aminer slike som diethylamin, dibu-tylamin, piperidin, ^-methylpiperidin, morfolin. Of amines 2, which are useful in the reaction shown above, the following examples can be mentioned: - ammonia or a compound which is a potential source of ammonia, for example hexamethylenetetramine and the like, primary amines such as ethylamine, propylamine and the like, secondary amines such as diethylamine, dibutylamine, piperidine, β-methylpiperidine, morpholine.
Aminering av bis-(iJ-halogenalkanoyl)-dibenzothiofen kan utfores under forskjellige betingelser. Eksempelvis kan forbindelsen 1 oppvarmes med et-stort overskudd av aminet 2, hvorved overskudd av amin tjener som reaksjonsmedium <p>g som hydrogenhalogenidakseptor. Denne metode.er spesielt egnet for lett tilgjengelige aminer, overskudd av aminer kan lett fjernes fra reaksjonsblandingen, eksempelvis ved destillering under redusert trykk eller ved å vaske produktet med vann. Eller, en ekvivalent av forbindelsen 1 Amination of bis-(1H-haloalkanoyl)-dibenzothiophene can be carried out under various conditions. For example, the compound 1 can be heated with a large excess of the amine 2, whereby the excess of amine serves as a reaction medium <p>g as a hydrogen halide acceptor. This method is particularly suitable for readily available amines, excess amines can be easily removed from the reaction mixture, for example by distillation under reduced pressure or by washing the product with water. Or, an equivalent of compound 1
og h ekvivalenter av aminet 2, kan oppvarmes sammen i en av et antall forskjellige opplosningsmidler, eksempelvis i aromatiske opp- and h equivalents of the amine 2, can be heated together in one of a number of different solvents, for example in aromatic solvents
løsningsmidler som "benzen, toluen, xylen og lignende eller andre slike som tetrahydrofuran, dioxan og lignende, eller ketoner slike som aceton, butanon og lignende, eller aprotiske opplosningsmidler slike som N,N-dimethylformamid, N,N-dimethylacetamid, dimethyl-sulfoxyd og lignende, eller blandinger av disse opplosningsmidler med vann. Reaksjonen mellom forbindelsen 1, hvor halogenet er Cl, solvents such as "benzene, toluene, xylene and the like or others such as tetrahydrofuran, dioxane and the like, or ketones such as acetone, butanone and the like, or aprotic solvents such as N,N-dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide and the like, or mixtures of these solvents with water.The reaction between compound 1, where the halogen is Cl,
og aminet 2, kan ofte fremmes ved tilsetning av entennatrium eller kaliumjodid, hvor jodidet anvendes enten i katalytiske eller stokio-metriske mengder. I visse tilfeller kan det være fordelaktig å bare anvende to ekvivalenter av aminet 2, for hver ekvivalent av bis-(w-halogenalkanoyl)-dibenzothiofen 1, idet det anvendes et overskudd av en uorganisk base, slik som pulverisert natrium- eller kalium-carbonat, som en hydrogenhalogenidakseptor. Reaksjonen vil normalt forlope i 12 - 72 timer ved temperaturer i området 20 - 150°C Da det anvendes flyktige aminer utfores reaksjonen best under trykk i egnede trykk-reaktorer eller autoklaver. and the amine 2, can often be promoted by the addition of sodium or potassium iodide, where the iodide is used either in catalytic or stoichiometric amounts. In certain cases it may be advantageous to use only two equivalents of the amine 2, for each equivalent of bis-(w-haloalkanoyl)-dibenzothiophene 1, using an excess of an inorganic base, such as powdered sodium or potassium carbonate , as a hydrogen halide acceptor. The reaction will normally proceed for 12 - 72 hours at temperatures in the range 20 - 150°C When volatile amines are used, the reaction is best carried out under pressure in suitable pressure reactors or autoclaves.
(II) Forbindelser av formel I, hvor A er en alkylenkjede med 3-6 carbonatomer, kan også fremstilles ved å omsette et Grignard-reagens med et dinitril av dibenzothiofen, som vist ved den folgende reaksjon: (II) Compounds of formula I, where A is an alkylene chain of 3-6 carbon atoms, can also be prepared by reacting a Grignard reagent with a dinitrile of dibenzothiophene, as shown by the following reaction:
I den ovenfor viste reaksjon er X brom eller klor, z er fra 3 til 6 og Y kan være hvilke som helst av de tidligere definerte grupper In the reaction shown above, X is bromine or chlorine, z is from 3 to 6 and Y can be any of the previously defined groups
bortsett fra de som inneholder et hydrogen direkte knyttet til nitrogenatomet. except those containing a hydrogen directly attached to the nitrogen atom.
Reaksjonen vil forlope i 1 - 2h timer ved en temperatur i området fra romtemperatur til ca. 80°C. Grignard-reagenset h kan fremstilles ved å omsette magnesium med et aminoalkylhalogenid av formelen The reaction will proceed for 1 - 2 hours at a temperature in the range from room temperature to approx. 80°C. The Grignard reagent h can be prepared by reacting magnesium with an aminoalkyl halide of the formula
hvor X, z og Y har de tidligere angitte betydninger. Et foretrukket opplosningsmiddel for denne reaksjon er tetrahydrofuran. where X, z and Y have the previously stated meanings. A preferred solvent for this reaction is tetrahydrofuran.
Dicyandibenzothiofenderivatet 3, kan fremstilles fra kjente diaminer ved Sandmeyer-reaksjon på tetrazoniumsaltene eller fra kjente dibenzothiofendicarboxylsyrer ved dehydrering av de tilsvarende amider, ved standard fremgangsmåter. The dicyandibenzothiophene derivative 3 can be prepared from known diamines by Sandmeyer reaction on the tetrazonium salts or from known dibenzothiophenedicarboxylic acids by dehydration of the corresponding amides, by standard methods.
(III) Forbindelsene' av formel I, hvor A er -CH^CR^- og hver Y er hvilket som helst sekundært amin, som tidligere definert, kan også fremstilles ved hjelp av en Mannich-reaksjon, som vist i den folgende reaksjon: (III) The compounds' of formula I, where A is -CH^CR^- and each Y is any secondary amine, as previously defined, can also be prepared by means of a Mannich reaction, as shown in the following reaction:
Ved å omsette en ekvivalent av forbindelsen 6 med to eller flere ekvivalenter av forbindelsen 2 med tre eller flere ekvivalenter formaldehyd 7, vil reaksjonen forlope i 1 - 2h timer i opplosningsmidler slike som vann, eddiksyre, ethanol, butanol, dioxan, tetrahydrofuran og lignende, ved temperaturer tilsvarende tilbakelops-temperaturen for det anvendte opplosningsmiddel. Ved denne reaksjon kan anvendes to kilder for formaldehyd. Når formalin anvendes utfores reaksjonen med en suspensjon av forbindelsen 6 eller det kan tilsettes et ytterligere opplosningsmiddel som methanol, for å tillate at reaksjonen forlbper i et homogent medium. Når kilden for formaldehyd er paraformaldehyd, utfores reaksjonen i et organisk opplosningsmiddel, slike som nevnt ovenfor. I enkelte tilfeller er det bnskelig å tilsette et lite overskudd av saltsyre for å frem-me depolymeriseringen av formaldehyd, enten under reaksjonen eller ved reaksjonens slutt. By reacting one equivalent of compound 6 with two or more equivalents of compound 2 with three or more equivalents of formaldehyde 7, the reaction will proceed for 1 - 2 hours in solvents such as water, acetic acid, ethanol, butanol, dioxane, tetrahydrofuran and the like, at temperatures corresponding to the reflux temperature for the solvent used. In this reaction, two sources of formaldehyde can be used. When formalin is used, the reaction is carried out with a suspension of compound 6 or an additional solvent such as methanol can be added to allow the reaction to proceed in a homogeneous medium. When the source of formaldehyde is paraformaldehyde, the reaction is carried out in an organic solvent, such as mentioned above. In some cases, it is desirable to add a small excess of hydrochloric acid to promote the depolymerization of formaldehyde, either during the reaction or at the end of the reaction.
Det sekundære amin, forbindelsen 2, som anvendes ved denne reaksjon, kan tilsettes reaksjonsmediet enten som et salt eller som basen, under en etterfølgende in situ dannelse av saltet ved tilsetning av syre. Foretrukne syrer er uorganiske syrer, eksempelvis saltsyre. Av typiske sekundære aminer som kan utnyttes i den ovenfor viste reaksjon, kan eksempelvis nevnes: dimethylamin, dibutyl-amin, piperidin, h-methylpiperidin, morfolin. The secondary amine, compound 2, which is used in this reaction, can be added to the reaction medium either as a salt or as the base, with subsequent in situ formation of the salt by addition of acid. Preferred acids are inorganic acids, for example hydrochloric acid. Examples of typical secondary amines that can be used in the reaction shown above include: dimethylamine, dibutylamine, piperidine, h-methylpiperidine, morpholine.
Diacetyldibenzothiofen forbindelsen 6, kan fremstilles ved en Friedel-Craft-acyleringsreaksjon på dibenzothiofen, eller ved en Grignard reaksjon mellom dicyandibenzothiofen 3, °g methylmagne-siumhalogenid. Dicyandibenzothiofen-forbindelsen kan erholdes ved de tidligere beskrevne metoder. The diacetyldibenzothiophene compound 6 can be prepared by a Friedel-Craft acylation reaction on dibenzothiophene, or by a Grignard reaction between dicyandibenzothiophene 3 and methylmagnesium halide. The dicyandibenzothiophene compound can be obtained by the previously described methods.
I det etterfølgende illustreres fremstilling av utgangsmaterialer, og fremstilling av forbindelser ifolge formel I. In the following, the preparation of starting materials and the preparation of compounds according to formula I are illustrated.
A. Fremstilling av utgangsmaterialer A. Preparation of starting materials
1) 2,8-bisC+-klorbutyryl)-dibenzothiofen 1) 2,8-bisC+-chlorobutyryl)-dibenzothiophene
Til en oppløsning av 200 g (1,09 mol) dibenzothiofen og 380 g (2,7 mol) Lf-klorbutyrylklorid i 2 liter methylenklorid, som tidligere var avkjølt til 0°C, ble tilsatt porsjonsvis 36O g (2,7 mol) aluminiumklorid under omroring. Reaksjonsblandingen ble omrort ved romtemperatur i 2h timer hvoretter reaksjonsblandingen ble spal-tet med en blanding av Isvann og saltsyre. Methylenklorid et ble fjernet og det urene produkt omkrystallisert fra en blanding av kloroform og aceton, hvorved det ble erholdt den onskede forbindelse. To a solution of 200 g (1.09 mol) dibenzothiophene and 380 g (2.7 mol) Lf-chlorobutyryl chloride in 2 liters of methylene chloride, which had previously been cooled to 0°C, 360 g (2.7 mol) were added in portions aluminum chloride while stirring. The reaction mixture was stirred at room temperature for 2 hours, after which the reaction mixture was split with a mixture of ice water and hydrochloric acid. Methylene chloride was removed and the crude product recrystallized from a mixture of chloroform and acetone to give the desired compound.
Sm.p. 131 133 °C,^^ks3 263' E?cm<1>7°°- Sm.p. 131 133 °C,^^ks3 263' E?cm<1>7°°-
2) 2,6-bi s (>+-klorbutyryl) -d ibenzo thiof en 2) 2,6-bi s (>+-chlorobutyryl)-dibenzothiophene
Ved å anvende fremgangsmåten i henhold til 1), men anvende kloroform ved omkrystalliseringen av det urene produkt, By applying the method according to 1), but using chloroform in the recrystallization of the impure product,
ble erholdt den onskede forbindelse. Sm.p. 1^7 - 1^8,5°C, the desired connection was obtained. Sm.p. 1^7 - 1^8.5°C,
71 CH1C13 256, 1190. 71 CH1C13 256, 1190.
maksJ y ' lem y maxJ y ' limb y
3) 3)
Ved å anvende fremgangsmåten i henhold til 1), men erstatte ^f-klorbutyrylklorid med kloracetylklorid, erholdes en blanding av 2,6- og 2,8-bis(kloracetyl)-dibenzothiofen, som omkrystalliseres fra en blanding av dimethylformamid og methanol. By applying the method according to 1), but replacing β-chlorobutyryl chloride with chloroacetyl chloride, a mixture of 2,6- and 2,8-bis(chloroacetyl)-dibenzothiophene is obtained, which is recrystallized from a mixture of dimethylformamide and methanol.
Sm.p. 210 - 212 °C. Sm.p. 210 - 212 °C.
V) 2,8-bis-(bromacetyl)-dibenzothiofen V) 2,8-bis-(bromoacetyl)-dibenzothiophene
Til en opplosning av 5,0 g (0,019 mol) 2,8-diacetyldibenzothiofen i 200 ml kloroform ble tilsatt dråpevis, under omroring og forsiktig tilbakelop, 6,1 g (0,038 mol) brom i 25 ml kloroform. Etter koking med tilbakelop i ytterligere 1 time ble reaksjon sbl and ing en avkjolt og det onskede produkt frafiltrert og om-krystalli sert fra eddiksyre. Sm.p. 187 - 189°C (spaltning). To a solution of 5.0 g (0.019 mol) of 2,8-diacetyldibenzothiophene in 200 ml of chloroform was added dropwise, with stirring and gentle reflux, 6.1 g (0.038 mol) of bromine in 25 ml of chloroform. After refluxing for a further 1 hour, the reaction mixture was cooled and the desired product filtered off and recrystallized from acetic acid. Sm.p. 187 - 189°C (decomposition).
B. Fremstilling av forbindelser av formel I B. Preparation of compounds of formula I
Eksempel 1 Example 1
2,6-bi s-( h-piperidinobutyryl)-dibenzothiofen 2,6-bi s-(h-piperidinobutyryl)-dibenzothiophene
En blanding av 1^,0 g (0,036 mol) 2,6-bis-(^-klor-butyryl)-dibenzothiofen(2)), 2<1>+,7 g (0,29 mol) piperidin og 12,0 g (0,072 mol) kaliumjodid i 300 ml butanon ble kokt under tilbakelop i 3 dager hvoretter reaksjonsblandingen ble avkjolt og fortynnet med 1000 ml vann. Det utfelte faststoff ble frafiltrert, vasket med vann og omkrystallisert fra en blanding av kloroform og aceton, hvorved det ble erholdt den onskede forbindelse, sm.p. 106 - 108°C, A mixture of 1^.0 g (0.036 mol) 2,6-bis-(^-chloro-butyryl)-dibenzothiophene(2)), 2<1>+.7 g (0.29 mol) piperidine and 12, 0 g (0.072 mol) of potassium iodide in 300 ml of butanone was refluxed for 3 days after which the reaction mixture was cooled and diluted with 1000 ml of water. The precipitated solid was filtered off, washed with water and recrystallized from a mixture of chloroform and acetone to give the desired compound, m.p. 106 - 108°C,
*£a£s3 256, E^m 9^7. *£a£s3 256, E^m 9^7.
Eksempel 2 Example 2
2,8-bi s- (!+-mor f olinobutyryl)-dibenzothiof en-dihydr oklor id 2,8-bi s-(!+-mor f olinobutyryl)-dibenzothiophene-dihydro chlor id
En blanding av 20 g (0,05 mol) 2,8-bis-(lf-klorbu1yryl)-dibenzothiof en (l)), 32 g (0,32 mol) morfolin og 2,0 g kaliumjodid i 500 ml p-dioxan ble kokt under tilbakelop i 72 timer hvoretter reaksjon sbl and ing en ble avkjolt og filtrert. Filtratet ble konsentrert til halvdelen av det opprinnelige volum og fortynnet med 700 ml vann, hvorved det ble erholdt et halvfast bunnfall som ble vasket med vann og opplost i methylenklorid. Methylenklorfdoppløsningen vaskes med vann, torkes over magnesiumsulfat og behandles med en etherisk opp-lbsning av HC1, hvorved ble erholdt den onskede forbindelse som ble omkrystallisert fra en blanding av methanol og ethylacetat, sm.p. A mixture of 20 g (0.05 mol) 2,8-bis-(1-chlorobutyl)-dibenzothiophene (l)), 32 g (0.32 mol) morpholine and 2.0 g potassium iodide in 500 ml p- dioxane was refluxed for 72 hours, after which the reaction mixture was cooled and filtered. The filtrate was concentrated to half the original volume and diluted with 700 ml of water, whereby a semi-solid precipitate was obtained which was washed with water and dissolved in methylene chloride. The methylene chloride solution is washed with water, dried over magnesium sulfate and treated with an ethereal solution of HCl, whereby the desired compound was obtained which was recrystallized from a mixture of methanol and ethyl acetate, m.p.
2hl - 2^2°C, /?E\°H 2h0, E^ 968. 2hl - 2^2°C, /?E\°H 2h0, E^ 968.
' "maks ' lem ' ' "max ' limb '
Eksempel 3 Example 3
2,8-bi s-( h-piperidinobutyryl)-dibenzothiofen 2,8-bi s-(h-piperidinobutyryl)-dibenzothiophene
En blanding av 28,0 g (0,072 mol) 2,8-bis-(If-klorbutyryl)-dibenzothiofen (l)), >+9,4- g (0,58 mol) piperidin og 2,0 g kaliumjodid i 200 ml tetrahydrofuran ble oppvarmet ved 125°C med omroring i 2h timer i en Paar-bombe. Reaksjonsblandingen ble avkjolt, filtrert og filtratet inndampet i vakuum, hvorved det erholdes et residum som vaskes med vann og omkrystalliseres to ganger fra aceton, hvilket ga den onskede forbindelse, sm.p. 93 - 95 o C, /\ Etk OH 260, A mixture of 28.0 g (0.072 mol) 2,8-bis-(If-chlorobutyryl)-dibenzothiophene (l)), >+9.4- g (0.58 mol) piperidine and 2.0 g potassium iodide in 200 ml of tetrahydrofuran was heated at 125°C with stirring for 2 hours in a Paar bomb. The reaction mixture was cooled, filtered and the filtrate evaporated in vacuo to give a residue which was washed with water and recrystallized twice from acetone to give the desired compound, m.p. 93 - 95 o C, /\ Etk OH 260,
-i df man. b -in df mon. b
<E>t/0<1>350.<E>h/0<1>350.
lem Jy limb Jy
Eksempel k- Example k-
2,8-bi s- (■+- (!+-methylpiperidino) -butyryl) -dibenzothiof en 2,8-bi s-(■+-(!+-methylpiperidino)-butyryl)-dibenzothiophene
Ved å anvende fremgangsmåten i henhold til eksempel 3 men erstatte piperidin med 57,^2 g (0,58 mol) k—methylpiperidin og omkrystallisere -fra en blanding av kloroform og aceton, erholdes den onskede forbindelse. Sm.p. 136 - 137,5°C /l^aks260' Elcm 128°-By using the method according to Example 3 but replacing piperidine with 57.2 g (0.58 mol) of n-methylpiperidine and recrystallizing from a mixture of chloroform and acetone, the desired compound is obtained. Sm.p. 136 - 137.5°C /l^aks260' Elcm 128°-
Eksempel 5 Example 5
2,8-bis( h-(dimethylamino)-butyryl)dibenzothiofen-dihydroklorid 2,8-bis(h-(dimethylamino)butyryl)dibenzothiophene dihydrochloride
Ved å anvende fremgangsmåte i henhold til eksempel 3, men erstatte piperidin med 200 ml av en 25 $-ig vandig opplosning av dimethylamin, erholdes 2,8-bis(1+-(dimethylamino)butyryl)dibenzothiofen som opploses i ether og behandles med en etherisk opplosning av HC1 og omkrystalliseres fra en blanding av methanol og aceton, hvorved erholdes dikloridsaltet, sm.p. 276 - 277,5°C, By using the method according to example 3, but replacing piperidine with 200 ml of a 25 µg aqueous solution of dimethylamine, 2,8-bis(1+-(dimethylamino)butyryl)dibenzothiophene is obtained, which is dissolved in ether and treated with an ethereal solution of HC1 and recrystallized from a mixture of methanol and acetone, whereby the dichloride salt is obtained, m.p. 276 - 277.5°C,
^H2,° 261, E^ 12h0. ^H2,° 261, E^ 12h0.
'1 maks ' lem '1 max ' limb
Eksempel 6 Example 6
En blanding av 1^,0 g (0,0^2 mol) 2,6- og 2,8-bis-(kloracetyl)-dibenzothiof en (3)) og 100 ml diethylamin i 150 ml tetrahydrofuran ble kokt under tilbakelop i 2 timer, avkjolt til romtemperatur og filtrert. Filtratet ble inndampet I vakuum og residuet opplost i ether, behandlet med den etheriske opplosning av HC1 og omkrystallisert fra en blanding av methanol og ethylacetat til å gi en blanding av 2,6- og 2,8-bis-(diethylaminoacetyl)-dibenzothiofen-dihydrokloriddihydrat, sm.p. 203 - 207°C, A maks 257 > Elim 9h2'A mixture of 1^.0 g (0.0^2 mol) of 2,6- and 2,8-bis-(chloroacetyl)-dibenzothiophene (3)) and 100 ml of diethylamine in 150 ml of tetrahydrofuran was refluxed in 2 hours, cooled to room temperature and filtered. The filtrate was evaporated in vacuo and the residue dissolved in ether, treated with the ethereal solution of HCl and recrystallized from a mixture of methanol and ethyl acetate to give a mixture of 2,6- and 2,8-bis-(diethylaminoacetyl)-dibenzothiophene- dihydrochloride dihydrate, m.p. 203 - 207°C, A max 257 > Elim 9h2'
Eksempel 7 Example 7
En blanding av l<>>+,0 g (0,0^-2 mol) 2,6- og 2,8-bis-(kloracetyl)-dibenzothiofen (3 j) og et stort overskudd av dimethylamin i l^O ml tetrahydrofuran ble oppvarmet ved 65~75Ci20 timer i en Paar-reaksjonsbombe, og deretter filtrert. Filtratet ble inndampet A mixture of l<>>+.0 g (0.0^-2 mol) of 2,6- and 2,8-bis-(chloroacetyl)-dibenzothiophene (3 j) and a large excess of dimethylamine in l^0 ml tetrahydrofuran was heated at 65~75Ci20 hours in a Paar reaction bomb, then filtered. The filtrate was evaporated
i vakuum og residuet opplost i ether og behandlet med en etherisk opplosning av HC1, hvorved ble erholdt en blanding av 2,6- og 2,8-bis-(dimethylaminoacetyl)-dibenzothiofendihydrokloriddihydrat, som ble omkrystallisert fra en blanding av methanol og ethylacetat, 217°C, A Siks 2^, 4cm in vacuo and the residue dissolved in ether and treated with an ethereal solution of HCl, whereby a mixture of 2,6- and 2,8-bis-(dimethylaminoacetyl)-dibenzothiophene dihydrochloride dihydrate was obtained, which was recrystallized from a mixture of methanol and ethyl acetate, 217°C, A Six 2^, 4cm
Eksempel 8 Example 8
2,8-bis-(dimethylaminoacetyl)-dibenzothiofen-dihydrokiorid 2,8-bis-(dimethylaminoacetyl)-dibenzothiophene dihydrochloride
En blanding av l8, h g (0,05 mol) 2,8-bis-(bromacetyl)-dibenzothiofen (^j) og 25 g (0,57 mol)dimethylamin i 350 ml tetrahydrofuran ble oppvarmet til 60°C i 3 timer i en rustfri stålreåksjons-bombe. Overskudd av amin og opplosningsmiddel ble fjernet i vakuum og det resulterende residuum opplost i ether og behandlet med en etherisk opplosning av HC1, hvorved ble erholdt den onskede forbindelse som ble omkrystallisert fra en blanding av methanol og ether. Sm.p.^0°C, A JJ§£s 261, E^m 1236. A mixture of 18.1 g (0.05 mol) of 2,8-bis-(bromoacetyl)-dibenzothiophene (^j) and 25 g (0.57 mol) of dimethylamine in 350 ml of tetrahydrofuran was heated to 60°C for 3 hours. in a stainless steel reaction bomb. Excess amine and solvent were removed in vacuo and the resulting residue dissolved in ether and treated with an ethereal solution of HCl to give the desired compound which was recrystallized from a mixture of methanol and ether. Sm.p.^0°C, A JJ§£s 261, E^m 1236.
Eksempel 9 Example 9
Ved å folge fremgangsmåten i henhold til eksempel 8, men erstatte dimethylamin med et stort overskudd av diethylamin fremstilles 2,8-bis-(2-diethylaminoacetyl)-dibenzothiofen-dihydro-ki orid. By following the procedure according to example 8, but replacing dimethylamine with a large excess of diethylamine, 2,8-bis-(2-diethylaminoacetyl)-dibenzothiophene-dihydro-chloride is prepared.
Claims (3)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3390270A | 1970-05-01 | 1970-05-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO131836B true NO131836B (en) | 1975-05-05 |
NO131836C NO131836C (en) | 1975-08-13 |
Family
ID=21873118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO1543/71A NO131836C (en) | 1970-05-01 | 1971-04-26 |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS553352B1 (en) |
AT (1) | AT302290B (en) |
BE (1) | BE766577A (en) |
CA (1) | CA950456A (en) |
CH (1) | CH560212A5 (en) |
CS (1) | CS180573B2 (en) |
DE (1) | DE2120996C3 (en) |
ES (1) | ES390707A1 (en) |
FR (1) | FR2092120B1 (en) |
GB (1) | GB1292567A (en) |
HU (1) | HU165245B (en) |
IE (1) | IE35180B1 (en) |
IL (1) | IL36644A (en) |
NL (1) | NL7105854A (en) |
NO (1) | NO131836C (en) |
PH (1) | PH9507A (en) |
SE (1) | SE387346B (en) |
ZA (1) | ZA712219B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3083201A (en) * | 1961-02-13 | 1963-03-26 | Smith Kline French Lab | Glyoxal derivatives of dibenzofuran and dibenzothiophene |
US3867409A (en) * | 1969-06-16 | 1975-02-18 | Richardson Merrell Inc | Bis-basic esters of dibenzofuran |
-
1971
- 1971-04-06 CA CA109,720,A patent/CA950456A/en not_active Expired
- 1971-04-07 ZA ZA712219A patent/ZA712219B/en unknown
- 1971-04-16 PH PH12372*UA patent/PH9507A/en unknown
- 1971-04-18 IL IL36644A patent/IL36644A/en unknown
- 1971-04-21 JP JP2533371A patent/JPS553352B1/ja active Pending
- 1971-04-26 NO NO1543/71A patent/NO131836C/no unknown
- 1971-04-27 AT AT362971A patent/AT302290B/en not_active IP Right Cessation
- 1971-04-28 SE SE7105505A patent/SE387346B/en unknown
- 1971-04-28 HU HURI428A patent/HU165245B/hu unknown
- 1971-04-28 CH CH626371A patent/CH560212A5/xx not_active IP Right Cessation
- 1971-04-29 ES ES390707A patent/ES390707A1/en not_active Expired
- 1971-04-29 DE DE2120996A patent/DE2120996C3/en not_active Expired
- 1971-04-29 NL NL7105854A patent/NL7105854A/xx unknown
- 1971-04-30 FR FR7115646A patent/FR2092120B1/fr not_active Expired
- 1971-04-30 BE BE766577A patent/BE766577A/en unknown
- 1971-04-30 IE IE539/71A patent/IE35180B1/en unknown
- 1971-04-30 GB GB02495/71A patent/GB1292567A/en not_active Expired
- 1971-04-30 CS CS7100003179A patent/CS180573B2/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE2120996B2 (en) | 1979-08-02 |
IL36644A (en) | 1974-12-31 |
JPS553352B1 (en) | 1980-01-24 |
DE2120996C3 (en) | 1980-04-17 |
ES390707A1 (en) | 1973-06-16 |
HU165245B (en) | 1974-07-27 |
IE35180B1 (en) | 1975-12-10 |
IE35180L (en) | 1971-11-01 |
FR2092120B1 (en) | 1974-08-23 |
DE2120996A1 (en) | 1971-11-18 |
AT302290B (en) | 1972-10-10 |
GB1292567A (en) | 1972-10-11 |
NL7105854A (en) | 1971-11-03 |
ZA712219B (en) | 1972-01-26 |
BE766577A (en) | 1971-09-16 |
CA950456A (en) | 1974-07-02 |
SE387346B (en) | 1976-09-06 |
CS180573B2 (en) | 1978-01-31 |
CH560212A5 (en) | 1975-03-27 |
PH9507A (en) | 1976-01-09 |
FR2092120A1 (en) | 1972-01-21 |
IL36644A0 (en) | 1971-06-23 |
NO131836C (en) | 1975-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3772275A (en) | Antidepressive morpholino compounds and methods of producing the same | |
US4086353A (en) | Certain azolinylamino (azolidinylimino) indazoles | |
US3574199A (en) | 6-(aminoalkyl- and aminoalkylidene)-1,1a,6,10b -tetrahydro-dibenzo(a,e)cyclopropa(c)cycloheptenes | |
HU177120B (en) | Process for producing 4,5-dichloro-6-oxo-7-methyl-7-phenyl-1,2,7,8-tetrahydro-6h-indeno-square bracket-5,4-b-square bracket closed-furane-2-carboxylic acid | |
US4064347A (en) | Bis-basic ketones of fluorene and fluorenone | |
NO131836B (en) | ||
US3989722A (en) | 1-Aminomethyl-2,2-diaryl-cyclopropane carboxamides | |
US3720680A (en) | Bis-basic ethers and thioethers of dibenzothiophene | |
US3389138A (en) | Phenyl-alpha-piperazino-alkanoates | |
US3285912A (en) | Substituted diphenyl ketones | |
US3372162A (en) | 1-(2-thienyl)-1-oxo-2-amino propanes | |
US3932424A (en) | Bis-basic ethers of carbazole | |
US4229350A (en) | Dibenzo[d,g][1,3,6]dioxazocine derivatives | |
US3551435A (en) | Certain 4-(pyridylmethylene)-3,4-dihydro-1-benzothiepin-5(2h)-ones | |
US3646146A (en) | Diphenylcyclopropyl-methyl-amines | |
US3903092A (en) | 2-Tertiaryamino-1-(benzo{8 b{9 thienyl)ethanols | |
FI69841C (en) | FOERFARANDE FOER FRAMSTAELLNING AV THERAPEUTISKT ANVAENDBARA 1-PHENOXY- ELLER FENYLTIO- ELLER FENYLALKYL) -4-BENZIMIDOYLPI PEAZINER | |
US3159634A (en) | New aminoalkylindenes and aminoalkyl indanyl ethers | |
US3946021A (en) | Bis-basic ketones of carbazole | |
US2633468A (en) | Benzooxaheterocyclic bases and acid addition salts thereof | |
HU181736B (en) | Process for producing new 3-amino-1-benzoxepine derivatives | |
NO134656B (en) | ||
US4528294A (en) | Benzoyl-phenyl-piperidine derivatives | |
US3856789A (en) | Bis-basic ketones of thioxanthene | |
US3709937A (en) | Amides of hexahydro-4,7-methanoindan-2-carboxylic acid |